Testing effectiveness (Phase 2)Ended earlyNCT04176952
What this trial is testing
PRIMUS002: Looking at 2 Neo-adjuvant Treatment Regimens for Resectable and Borderline Resectable Pancreatic Cancer
Who this might be right for
Neoplasms Pancreatic
Judith Dixon-Hughes 31